HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA tobacco oversight bill passes to President

This article was originally published in The Rose Sheet

Executive Summary

Bipartisan legislation giving FDA regulatory responsibility over production, sale and marketing of tobacco products passes House June 12 after clearing Senate the day before. The Family Smoking Prevention and Tobacco Control Act moves next to the White House for signature promised by President Obama. H.R. 1256 requires agency to establish a Center for Tobacco Products within 90 days upon enactment of the law. Counting FDA's Center for Toxicological Research, tobacco brings total number of FDA centers to seven. User fees will fund program; legislators behind the bill maintain resources will not be diverted from other activities

You may also be interested in...



Direct Sales Industry Guidance Responds To ‘Increase In Questionable Earnings Claims’

Direct Selling Self-Regulatory Council and Direct Selling Association guidance aims to curb multi-level marketers’ misleading earnings claims, a practice increasing among health and wellness direct sellers during the COVID-19 pandemic.

CMS Proposes Medicare Payments For Home Dialysis Equipment, Supplies

Makers of innovative home-use dialysis machines will benefit from a newly proposed CMS rule that would qualify equipment for home-use dialysis for add-on Medicare payments.

Market Intel: Opportunities for Medtech In Mental Health (Part 1) – Transcranial Magnetic Stimulation

With the global pandemic leading to a big rise in mental health issues, medtech could have a role to play. In this first part of a two-part series focusing on mental health tech, Medtech Insight focuses on transcranial magnetic stimulation systems used to treat severe anxiety and depression, among other indications. Part two will focus on the skyrocketing use of telehealth, apps and light therapy.   

UsernamePublicRestriction

Register

ID1125347

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel